{"transactions":[{"id":3674989,"issuer":{"id":7783,"kind":"organization","name":"Inhibitor Therapeutics, Inc."},"owners":[{"id":160588,"kind":"person","name":"MAGRAB E. BRENDAN","position":1,"cik":"0001196062","reported_name":"MAGRAB E. BRENDAN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock Options","published_at":"2019-02-06T00:52:27.000Z","date":"2019-02-03","kind":"grant","acquired":true,"shares":986842,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":986842,"derivative":{"exercise_price":0.076,"exercise_date":"2020-02-03","expiration_date":"2029-02-03","underlying":"Common Stock","underlying_shares":986842},"source":{"system":"sec-edgar","filing":"0000899243-19-002708","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1042418/000089924319002708/doc4.xml","form_type":"4"}},{"id":3719815,"issuer":{"id":7783,"kind":"organization","name":"Inhibitor Therapeutics, Inc."},"owners":[{"id":160588,"kind":"person","name":"MAGRAB E. BRENDAN","position":1,"cik":"0001196062","reported_name":"MAGRAB E. BRENDAN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-12-26T22:15:21.000Z","date":"2018-12-20","kind":"grant","acquired":true,"shares":65000,"price":0.08,"value":5200.0,"ownership":{"direct":true},"balance_after":65000,"source":{"system":"sec-edgar","filing":"0000899243-18-031718","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1042418/000089924318031718/doc4.xml","form_type":"4"}},{"id":3994952,"issuer":{"id":7783,"kind":"organization","name":"Inhibitor Therapeutics, Inc."},"owners":[{"id":160588,"kind":"person","name":"MAGRAB E. BRENDAN","position":1,"cik":"0001196062","reported_name":"MAGRAB E. BRENDAN","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chairman of the Board"}}],"security":"Common Stock Options","published_at":"2018-03-15T22:39:26.000Z","date":"2018-03-13","kind":"grant","acquired":true,"shares":345000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"These options were granted subject to the approval of the majority stockholder of the registrant pursuant to an agreement between the majority stockholder and the registrant. In the event that the majority stockholder does not approve the option grant, the options will be canceled."}],"balance_after":345000,"derivative":{"exercise_price":0.2722,"exercise_date":"2019-03-13","expiration_date":"2028-03-13","underlying":"Common Stock","underlying_shares":345000},"source":{"system":"sec-edgar","filing":"0000899243-18-007628","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1042418/000089924318007628/doc4.xml","form_type":"4"}},{"id":4254755,"issuer":{"id":7783,"kind":"organization","name":"Inhibitor Therapeutics, Inc."},"owners":[{"id":160588,"kind":"person","name":"MAGRAB E. BRENDAN","position":1,"cik":"0001196062","reported_name":"MAGRAB E. BRENDAN","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chairman of the Board"}}],"security":"Restricted Stock Units","published_at":"2017-07-19T23:41:15.000Z","date":"2017-05-04","kind":"grant","acquired":true,"shares":65000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a right to receive one share of the issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The RSUs were issued to the reporting person on May 4, 2017, pursuant to a grant under the issuer's 2014 Equity Incentive Plan. The RSUs will vest in full on January 1, 2018, provided that if such vesting date is not during an open trading window, then such RSUs will vest on the first day that thereafter that is during an open trading window."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The RSUs were issued to the reporting person on May 4, 2017, pursuant to a grant under the issuer's 2014 Equity Incentive Plan. The RSUs will vest in full on January 1, 2018, provided that if such vesting date is not during an open trading window, then such RSUs will vest on the first day that thereafter that is during an open trading window."}],"balance_after":65000,"derivative":{"underlying":"Common Stock","underlying_shares":65000},"source":{"system":"sec-edgar","filing":"0000899243-17-018593","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1042418/000089924317018593/doc4.xml","form_type":"4"}}]}